0
May 1987, Vol 141, No. 5 >
Article | May 1987

Life-Threatening Metabolic Acidosis From Cholestyramine in an Infant With Renal Insufficiency FREE

Marilyn Pattison, MD; Stanley M. Lee, MD
Am J Dis Child. 1987;141(5):479-480. doi:10.1001/archpedi.1987.04460050021018.
Text Size: A A A
Published online
Article
References
Comments

Sir.—Cholestyramine is a bile acid—sequestrant antilipemic agent whose mechanism of action is that of an ion exchange resin. Chloride is released from the resin and is absorbed in exchange for bicarbonate across the bowel wall. Normally the increased chloride (acid) load is excreted by the kidneys, but in the presence of renal insufficiency, hyperchloremic acidosis may develop.1 Cholestyramine has been of value in the treatment of children with cholestasis resulting from biliary atresia and in the treatment of intractable diarrhea in infants.2,3 There are scattered case reports documenting the occurrence of hyperchloremic acidosis associated with cholestyramine therapy.4,5 We report a case of life-threatening metabolic acidosis in an infant with renal insufficiency.

Patient Report.—A 5-week-old male infant was admitted for poor feeding and weight loss. The child was the product of an uneventful full-term pregnancy and weighed 2700 g at birth. However, the child incurred significant

REFERENCES

1 +
Runeberg L, Miettinen TA, Nikkila EA:  Effect of cholestyramine on mineral excretion in man . Acta Med Scand 1972;;192:71-76.
2 +
Sharp HL:  Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts . J Pediatr 1976;;71:723-736.
3 +
Wagner Y, Berant M, Cohen N:  Cholestyramine in the management of infantile diarrhea . J Pediatr 1976;;88:153-154.
4 +
Kleinman PK:  Cholestyramine and metabolic acidosis . N Engl J Med 1974;;290:861.
5 +
Hartline JV:  Hyperchloremia, metabolic acidosis, and cholestyramine . J Pediatr 1976;;89: 155.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

1 +
Runeberg L, Miettinen TA, Nikkila EA:  Effect of cholestyramine on mineral excretion in man . Acta Med Scand 1972;;192:71-76.
2 +
Sharp HL:  Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts . J Pediatr 1976;;71:723-736.
3 +
Wagner Y, Berant M, Cohen N:  Cholestyramine in the management of infantile diarrhea . J Pediatr 1976;;88:153-154.
4 +
Kleinman PK:  Cholestyramine and metabolic acidosis . N Engl J Med 1974;;290:861.
5 +
Hartline JV:  Hyperchloremia, metabolic acidosis, and cholestyramine . J Pediatr 1976;;89: 155.

Correspondence

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems